The 340B program requires drugmakers who want to participate in Medicaid and Medicare to discount their prices for hospitals, ...

ClearBridge Investments, an investment management company, released its “ClearBridge Growth Strategy” first quarter 2025 ...

Highlights,Market sentiment surrounding AbbVie (NYSE:ABBV) has shifted following rating changes and price objective ...

SAN DIEGO, CA / ACCESS Newswire / April 9, 2025 / Robbins LLP reminds stockholders that a class action was filed against ...

Discover AbbVie's strong performance, with immunology growth and undervaluation despite challenges. Click here to read an ...

The European Commission (EC) has granted marketing authorization to Rinvoq (upadacitinib; 15mg, once daily), from US pharma ...

Ireland’s government remains confident in its ability to retain the country’s strategic position in pharmaceutical ...

RINVOQ is the first and only oral Janus kinase (JAK) inhibitor approved in the European Union (EU) to treat adult patients with giant cell arteritis (GCA) The approval ...

AbbVie (NYSE:ABBV) has been actively advancing its oncology portfolio with recent presentations at the AACR Annual Meeting, ...

President Donald Trump 's controversial global tariff plan is set to send the price of everyday items soaring.

That’s because Ray-Ban, along with other popular brands including Oakley, Oliver Peoples and Vogue Eyewear, is owned by the French-Italian eye-wear giant EssilorLuxottica SA, the biggest company in ...

New tariffs imposed by President Trump could lead to rising prices for US consumers on items ranging from luxury goods to everyday products.